Duyen Huynh

Duyen Huynh has a diverse work experience in the field of research and pharmaceuticals. Duyen started their career at Vietnam National University in 2010 as a Researcher, focusing on the bioassay and production of recombinant human Granulocyte Colony Stimulating Factor. Duyen then joined Michigan State University in 2012 as a Graduate Student Researcher, investigating the role of Leucine Zipper-bearing Kinase in lung squamous cell carcinoma and the role of Mixed-Lineage Kinase 3 in breast cancer metastasis.

In 2016, Duyen took up a role at Danapha Pharmaceutical Joint Stock company as an Administrative Assistant to the CEO. Duyen later became a Researcher, where they played a critical role in establishing and optimizing formulations of nano-technological herbal pharmaceuticals. Duyen also established lab and pilot scale batch manufacturing procedures, followed up on stability testing, and ensured compliance with GMP regulations.

Duyen's work experience continued at Novogene Europe, where they worked as a Laboratory Technician, and most recently, at Xap Therapeutics as a Research Associate.

Duyen Huynh pursued their Bachelor of Science in Biotechnology at Vietnam National University, HCMC, from 2006 to 2010. Duyen then went on to complete their Master of Science in Cell/Cellular and Molecular Biology at Michigan State University, from 2012 to 2015.